1. Home
  2. IGI vs NMRA Comparison

IGI vs NMRA Comparison

Compare IGI & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Investment Grade Defined Opportunity Trust Inc.

IGI

Western Asset Investment Grade Defined Opportunity Trust Inc.

N/A

Current Price

$15.83

Market Cap

91.8M

Sector

Finance

ML Signal

N/A

Logo Neumora Therapeutics Inc.

NMRA

Neumora Therapeutics Inc.

N/A

Current Price

$0.46

Market Cap

87.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
IGI
NMRA
Founded
N/A
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
91.8M
87.4M
IPO Year
2009
2023

Fundamental Metrics

Financial Performance
Metric
IGI
NMRA
Price
$15.83
$0.46
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $6.50
AVG Volume (30 Days)
14.0K
★ 1.9M
Earning Date
01-01-0001
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 5.23
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.08
$0.32
52 Week High
$16.83
$3.65

Technical Indicators

Market Signals
Indicator
IGI
NMRA
Relative Strength Index (RSI) 54.21 43.65
Support Level $15.56 $0.33
Resistance Level $16.31 $0.65
Average True Range (ATR) 0.16 0.08
MACD 0.05 0.02
Stochastic Oscillator 55.30 36.85

Price Performance

Historical Comparison
IGI
NMRA

About IGI Western Asset Investment Grade Defined Opportunity Trust Inc.

Western Asset Invstm Grd Dfnd Opp Tr Inc operates as a non-diversified closed-end management investment company. Its primary investment objective is to provide current income and then liquidate & distribute substantially all of the Fund's net assets to stockholders. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing at least 80% of its net assets in investment-grade corporate fixed-income securities of varying maturities.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Share on Social Networks: